![](/img/cover-not-exists.png)
A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer
Weijing Sun, Maureen R. Hewitt, Marry R. Theobald, Diane Hershock, Daniel G. HallerVolume:
110
Year:
2007
Language:
english
Pages:
7
DOI:
10.1002/cncr.23098
File:
PDF, 106 KB
english, 2007